Integrated care Leverage IMP’s multi-divisional structure (AUCNY, ARC, IMP Pathology) to offer bundled solutions across urology, radiation oncology, and diagnostic services, enhancing patient throughput and care coordination for hospitals and health systems.

Expansion footprint Target the 30+ location network and three core divisions to present scalable partnerships, centralized scheduling, and shared services that can reduce variability in patient access and improve regional reach for partner health systems.

Technology enablement Position IMP’s use of advanced radiation technologies (IGRT, RapidArc) and integrated pathology workflows as a value proposition for health systems seeking high-precision outcomes, data-driven decision making, and improved diagnostic timelines.

Quality and safety Highlight IMP’s DNA verification and strict chain-of-custody protocols in pathology as a differentiator for partnerships prioritizing diagnostic integrity, regulatory compliance, and risk reduction.

Financial opportunity With annual revenue in the mid six-figure to low seven-figure range and a physician-led model, approach midsize health systems and specialty networks seeking cost-effective, scalable specialty care expansion with experienced leadership.